Dietary Cholesterol Absorption Inhibitor [EPC]

92277 reported adverse events

Drugs of this class: EZETIMIBE EZETIMIBE AND SIMVASTATIN BEMPEDOIC ACID AND EZETIMIBE

These side effects are most commonly reported by patients taking drugs of the Dietary Cholesterol Absorption Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 5917
1 NAUSEA 5562
2 MYALGIA 5301
3 DIARRHOEA 4724
4 DRUG INEFFECTIVE 4648
5 DIZZINESS 4427
6 DYSPNOEA 4207
7 HEADACHE 4088
8 ARTHRALGIA 3733
9 PAIN 3677
See all common reactions for Dietary Cholesterol Absorption Inhibitor [EPC]

Drugs of the Dietary Cholesterol Absorption Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOW DENSITY LIPOPROTEIN INCREASED 622 0.0803
1 MYOPATHY 481 0.0556
2 BLOOD CREATINE PHOSPHOKINASE INCREASED 1193 0.0414
3 RHABDOMYOLYSIS 1611 0.0386
4 MYALGIA 5301 0.0311
5 CORONARY ARTERY DISEASE 924 0.0305
6 ANGINA PECTORIS 807 0.0281
7 BLOOD TRIGLYCERIDES INCREASED 484 0.0274
8 BLOOD CHOLESTEROL INCREASED 1054 0.0226
9 PANCREATITIS ACUTE 420 0.0187
See all enriched reactions for Dietary Cholesterol Absorption Inhibitor [EPC]